Nectar Lifesciences Ltd. - Research Center

---

Results

• Quarterly
• Half yearly
• Annual

Statement

• Balance sheet
• P&L
• Cash flow

More

• Dividend
• Share holding
• Capital structures
• Ratio

Jun' 24	Mar' 24	Dec' 23	Sep' 23	Jun' 23

Sales

359.30

441.37

452.17

397.96

394.12

Operating profit

39.80

48.51

42.19

26.86

35.54

Interest

19.98

24.16

24.84

20.52

17.62

Gross profit

20.38

25.82

17.83

16.95

18.39

EPS (Rs)

0.13

0.03

0.07

0.05

0.08

Other income

0.55

1.47

0.48

10.61

0.47

Stock adjustment

-59.64

-52.39

-14.96

31.63

-4.49

Raw material

296.98

360.32

342.32

256.16

283.65

Power and fuel

-

-

-

-

-

Employee expenses

23.99

23.94

21.62

20.31

18.80

Excise

-

-

-

-

-

Admin and selling expenses

-

-

-

-

-

Research and development expenses

-

-

-

-

-

Expenses capitalised

-

-

-

-

-

Other expenses

58.17

61.00

60.99

63.00

60.62

Provisions made

-

-

-

-

-

Depreciation

15.46

14.70

15.37

15.31

15.33

Taxation

1.95

10.52

0.89

0.63

1.24

Net profit / loss

2.97

0.60

1.57

1.02

1.82

Extra ordinary item

-

-

-

-

-

Prior year adjustments

-

-

-

-

-

Equity capital

22.43

22.43

22.43

22.43

22.43

Equity dividend rate

-

-

-

-

-

Agg.of non-prom. shares (Lacs)

-

-

-

-

-

Agg.of non promotoholding (%)

-

-

-

-

-

OPM (%)

11.08

10.99

9.33

6.75

9.02

GPM (%)

5.66

5.83

3.94

4.15

4.66

NPM (%)

0.83

0.14

0.35

0.25

0.46